You are here

cancer

A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here's What It Teaches Us

A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here's What It Teaches Us

Forbes

clinical trials

Flag link:

New report heralds a revolution in cancer R&D trends – and the sticker shock that comes with it

New report heralds a revolution in cancer R&D trends – and the sticker shock that comes with it

Endpoints

drug development

Flag link:

Novartis sees gaps in cancer pipeline but is adamant it doesn’t need an I-O deal

Novartis sees gaps in cancer pipeline but is adamant it doesn’t need an I-O deal

Fierce Biotech

immuno-oncology

Flag link:

On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy

On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy

Xconomy

Bristol-Myers Squibb

Flag link:

Pioneering Merck makes another breakthrough with PD-1 star Keytruda, grabbing first OK for a cancer biomarker

Pioneering Merck makes another breakthrough with PD-1 star Keytruda, grabbing first OK for a cancer biomarker

Endpoints

Flag link:

Teva says it's eyeing a debt-cutting sale of its cancer meds

Teva says it's eyeing a debt-cutting sale of its cancer meds

Fierce Pharma

Teva Pharmaceutical

Flag link:

Bristol-Myers preps second checkpoint/cancer vax combo study under its $1B Bavarian Nordic pact

Bristol-Myers preps second checkpoint/cancer vax combo study under its $1B Bavarian Nordic pact

Endpoints

Bristol-Myers Squibb

Bavarian Nordic

Flag link:

Hey Pfizer, Novartis and Eli Lilly. G1 Therapeutics says it can beat all of you in its $115M IPO

Hey Pfizer, Novartis and Eli Lilly. G1 Therapeutics says it can beat all of you in its $115M IPO

Endpoints

G1 Therapeutics

Flag link:

The cost of cancer: new drugs show success at a steep price

The cost of cancer: new drugs show success at a steep price

Yahoo/Reuters

Bristol-Myers Squibb

Flag link:

How AbbVie Is Attacking Tumors at Their Roots

How AbbVie Is Attacking Tumors at Their Roots

Motley Fool

Flag link:

Cancer patients skipping medicines or delaying treatment due to high drug prices

Cancer patients skipping medicines or delaying treatment due to high drug prices

Stat

Flag link:

Billionaire-backed Chi-Med declares PhIII success for pioneering cancer drug in China, seeking quick OK

Billionaire-backed Chi-Med declares PhIII success for pioneering cancer drug in China, seeking quick OK

Endpoints

Flag link:

MD Anderson Benches IBM Watson In Setback For Artificial Intelligence In Medicine

MD Anderson Benches IBM Watson In Setback For Artificial Intelligence In Medicine

Forbes

artificial intelligence

MD Anderson Cancer Center

Flag link:

5 trends being impacted by biomarkers

5 trends being impacted by biomarkers

BioPharma Dive

precision medicine

Flag link:

Most new, high-priced cancer drugs don’t even extend life for 10 weeks

Most new, high-priced cancer drugs don’t even extend life for 10 weeks

ARS Technica, UK

Flag link:

Amgen, Immatics In Cancer Drug Partnership

Amgen, Immatics In Cancer Drug Partnership

Investopedia

bispecific antibodies

Flag link:

A startup trying to get the human body to fight cancer just filed for an IPO

A startup trying to get the human body to fight cancer just filed for an IPO

Yahoo/Business Insider

Jounce Therapeutics

Flag link:

Ionis Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer

Ionis Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer

Yahoo

Flag link:

3 Big Advances In Cancer Treatment In 2016

3 Big Advances In Cancer Treatment In 2016

Motley Fool

Ariad Pharmaceuticals

Flag link:

Study: IBM Watson agrees with cancer docs on treatment options 90% of the time

Study: IBM Watson agrees with cancer docs on treatment options 90% of the time

Fierce Biotech

artificial intelligence

Flag link:

Pages